Cargando…
Beta Cell Imaging—From Pre-Clinical Validation to First in Man Testing
There are presently no reliable ways to quantify human pancreatic beta cell mass (BCM) in vivo, which prevents an accurate understanding of the progressive beta cell loss in diabetes or following islet transplantation. Furthermore, the lack of beta cell imaging hampers the evaluation of the impact o...
Autores principales: | Demine, Stephane, Schulte, Michael L., Territo, Paul R., Eizirik, Decio L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582644/ https://www.ncbi.nlm.nih.gov/pubmed/33019671 http://dx.doi.org/10.3390/ijms21197274 |
Ejemplares similares
-
Pro-inflammatory cytokines induce cell death, inflammatory responses, and endoplasmic reticulum stress in human iPSC-derived beta cells
por: Demine, Stéphane, et al.
Publicado: (2020) -
ER stress and the decline and fall of pancreatic beta cells in type 1 diabetes
por: Brozzi, Flora, et al.
Publicado: (2016) -
Imaging of Human Insulin Secreting Cells with Gd-DOTA-P88, a Paramagnetic Contrast Agent Targeting the Beta Cell Biomarker FXYD2γa
por: Demine, Stéphane, et al.
Publicado: (2018) -
Molecular Footprints of the Immune Assault on Pancreatic Beta Cells in Type 1 Diabetes
por: Colli, Maikel L., et al.
Publicado: (2020) -
Construction and validation of the APOCHIP, a spotted oligo-microarray for the study of beta-cell apoptosis
por: Magnusson, Nils E, et al.
Publicado: (2005)